CN106562981A - 一种由知非沙班与人参皂苷Rb3组成的药物组合物及应用 - Google Patents
一种由知非沙班与人参皂苷Rb3组成的药物组合物及应用 Download PDFInfo
- Publication number
- CN106562981A CN106562981A CN201510670001.1A CN201510670001A CN106562981A CN 106562981 A CN106562981 A CN 106562981A CN 201510670001 A CN201510670001 A CN 201510670001A CN 106562981 A CN106562981 A CN 106562981A
- Authority
- CN
- China
- Prior art keywords
- ginsenoside
- shaban
- fei
- zifaxaban
- know
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
Description
组别 | 剂量(mg/kg) | 血栓湿重(mg) | 血栓基质重(mg) |
模型 | - | 21.64±6.83 | 2.48±0.78 |
知非沙班 | 10 | 11.48±3.48*** | 1.28±0.62*** |
人参皂苷Rb3 | 10 | 14.30±4.95* | 1.55±0.66** |
知非沙班:人参皂苷Rb3(1:1) | 10 | 8.83±2.73***△ | 0.94±0.41***△ |
知非沙班:人参皂苷Rb3(1:3) | 10 | 7.98±2.58***△△ | 0.83±0.40***△ |
知非沙班:人参皂苷Rb3(1:10) | 10 | 10.08±3.57*** | 1.09±0.40*** |
组别 | 剂量(mg/kg) | 出血时间(s) |
模型 | - | 1574±448 |
知非沙班 | 10 | 3335.6±1358** |
人参皂苷Rb3 | 10 | 3131.5±1108.9*** |
知非沙班:人参皂苷Rb3(1:1) | 10 | 2578.6±635.7*** |
知非沙班:人参皂苷Rb3(1:3) | 10 | 2077.9±581.8*△ |
知非沙班:人参皂苷Rb3(1:10) | 10 | 2355.9±556.5**△ |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510670001.1A CN106562981A (zh) | 2015-10-13 | 2015-10-13 | 一种由知非沙班与人参皂苷Rb3组成的药物组合物及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510670001.1A CN106562981A (zh) | 2015-10-13 | 2015-10-13 | 一种由知非沙班与人参皂苷Rb3组成的药物组合物及应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106562981A true CN106562981A (zh) | 2017-04-19 |
Family
ID=58508394
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510670001.1A Pending CN106562981A (zh) | 2015-10-13 | 2015-10-13 | 一种由知非沙班与人参皂苷Rb3组成的药物组合物及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106562981A (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102464658A (zh) * | 2010-11-03 | 2012-05-23 | 天津药物研究院 | 噁唑烷酮衍生物及其制备方法和用途 |
CN103242307A (zh) * | 2013-05-17 | 2013-08-14 | 天津药物研究院 | 一种噁唑烷酮类衍生物晶型ⅰ及其制备方法和用途 |
-
2015
- 2015-10-13 CN CN201510670001.1A patent/CN106562981A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102464658A (zh) * | 2010-11-03 | 2012-05-23 | 天津药物研究院 | 噁唑烷酮衍生物及其制备方法和用途 |
CN103242307A (zh) * | 2013-05-17 | 2013-08-14 | 天津药物研究院 | 一种噁唑烷酮类衍生物晶型ⅰ及其制备方法和用途 |
Non-Patent Citations (1)
Title |
---|
崔秀明等: "人参皂苷Rb3的抗血小板和抗血栓作用", 《中成药》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102670864A (zh) | 治疗心脑血管疾病和糖尿病的抗氧化功能的药物组合物 | |
CN106074496A (zh) | 大麻酚类化合物在制备治疗痛风药物中的应用 | |
Nguelefack et al. | Hypertensive effects of oral administration of the aqueous extract of Solanum torvum fruits in L-NAME treated rats: Evidence from in vivo and in vitro studies | |
CN103536610B (zh) | 三七皂苷Fc的医药用途 | |
JP2021520358A (ja) | 虚血再灌流損傷を予防及び/又は治療する漢方薬組成物 | |
CN104147032B (zh) | 一种用于防治缺血性中风相关疾病的药物组合物及其制备方法和用途 | |
CN101259139A (zh) | 一种用于消炎镇痛的药用组合物 | |
CN108785299A (zh) | 光甘草定在制备治疗血栓性疾病药物中的应用 | |
CN102228691A (zh) | 阿司匹林和一种抗血小板药物的药物组合物 | |
CN107349215A (zh) | 王不留行黄酮苷在制备抗血管钙化药物中的应用 | |
CN106562981A (zh) | 一种由知非沙班与人参皂苷Rb3组成的药物组合物及应用 | |
CN104055909A (zh) | 复方阿胶浆在制备经期保健的药物中的应用 | |
EA020344B1 (ru) | Средство для профилактики и лечения острого и хронического панкреатита | |
CN107468742B (zh) | 一种雷公藤多苷及雷公藤红素单体增效减毒配伍方法 | |
WO2018145364A1 (zh) | 3,4,7-三羟基异黄酮或3-甲氧基大豆素在制备抑制血小板聚集和血栓药物中的应用 | |
CN102205016B (zh) | 一种治疗动脉粥样硬化引起的痰浊血瘀冠心病的药物 | |
Nazemi et al. | The possible correlation between magnesium deficiency and SARS-CoV-2 infection | |
Altura et al. | HDFx and magnesium in combination ameliorates experimental pulmonary hypertension: Relevance to treatment of pulmonary hypertension in humans and newborns and the roles of hypomagnesemia, ceramides and PAF | |
CN103417565A (zh) | 解聚海参糖胺聚糖在制备防治血栓性疾病药物中的应用 | |
Huda et al. | Emerging Role of Nutraceuticals in Covid 19 | |
CN106620707A (zh) | 一种预防和治疗心肌缺血的药物组合物及其制备方法和用途 | |
CN106913565B (zh) | 甘草宁m在制备治疗和/或预防血栓性疾病的药物中的应用 | |
Jiun-Yi et al. | Anti-embolic effect of Taorenchengqi Tang in rats with embolic stroke induced by occluding middle cerebral artery | |
CN108653491A (zh) | 一种治疗心脑血管疾病的药 | |
CN105769882A (zh) | 一种抑制血栓形成的药物组合物及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: Binhai Binhai high tech Zone Technology Park Road 300450 No. 308 Tianjin Huiren Applicant after: Sun Shuangyong Applicant after: Wang Weiting Applicant after: Hao Chunhua Applicant after: Xi Wengong Applicant after: Xu Xiangwei Applicant after: Zhao Zhuanyou Applicant after: Tang Lida Address before: 300030 Tianjin City, Nankai District Anshan West Road No. 308 Applicant before: Sun Shuangyong Applicant before: Wang Weiting Applicant before: Hao Chunhua Applicant before: Xi Wengong Applicant before: Xu Xiangwei Applicant before: Zhao Zhuanyou Applicant before: Tang Lida |
|
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170419 |